INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

799 studies · page 2 of 34

2016 / Meta-analysis of observational studies

Obesity shows a weak link with cervical cancer, while overweight does not

A meta-analysis of nine observational reports with 128,233 participants evaluated body mass index and cervical malignancy. Overweight status was not linked to risk in case-control studies (OR: 1.03, 95% CI: 0.81, 1.25) but showed a slight relationship in cohort studies (OR: 1.10, 95% CI: 1.03, 1.17). Obesity had an estimated association of 1.40 (95% CI: 1.08, 1.71) in case-control and 1.08 (95% CI: 0.60, 1.52) in cohort designs.

Shows an association, not proof of cause and effect.

Poorolajal J, Jenabi E Eur J Cancer Prev, 2016. PMID 25932869

2016 / Systematic review and dose-response meta-analysis

Dietary cholesterol intake is associated with a modestly increased risk of endometrial cancer

A dose-response meta-analysis of one cohort and nine case-control studies investigated dietary cholesterol and endometrial cancer. Each 100 mg per day increase in cholesterol intake was associated with a 6% higher risk of endometrial cancer (OR = 1.06, 95% CI = 1.00-1.12), with marked heterogeneity (I2 = 64.2%). When restricted to case-control studies, the positive association remained significant (OR = 1.07, 95% CI = 1.01-1.13).

Gong TT, Li D, Wu QJ, et al. Oncotarget, 2016. PMID 26959738

2016 / Systematic review and population-attributable fraction analysis

Alcohol consumption, even at light levels, is linked to higher breast cancer risk.

A critical review evaluated 15 meta-analyses alongside global health databases to examine alcohol use and breast cancer risk. Thirteen of the 15 meta-analyses showed a dose-response association between alcohol intake and breast cancer risk. Globally in 2012, an estimated 144,000 breast cancer cases (95% CI: 88,000 to 200,000) and 38,000 breast cancer deaths (95% CI: 2,400 to 53,000) were linked to alcohol, with 18.8% of cases occurring in light drinkers.

Shield KD, Soerjomataram I, Rehm J Alcohol Clin Exp Res, 2016. PMID 27130687

2016 / Meta-analysis of prospective cohort studies

Higher whole grain intake was linked to lower risks of total, cardiovascular, and cancer mortality in a meta-analysis of prospective cohorts.

A meta-analysis evaluated 14 prospective cohort studies comprising 786,076 participants with 97,867 total deaths, 23,957 CVD deaths, and 37,492 cancer deaths. Comparing extreme categories (high vs. low intake), pooled relative risks were 0.84 (95% CI, 0.80-0.88) for total mortality, 0.82 (95% CI, 0.79-0.85) for CVD mortality, and 0.88 (95% CI, 0.83-0.94) for cancer mortality. Dose-response analysis demonstrated monotonic associations, where each 16-g/d increase in whole grains was associated with relative risks of 0.93 (95% CI, 0.92-0.94) for total mortality, 0.91 (95% CI, 0.90-0.93) for CVD mortality, and 0.95 (95% CI, 0.94-0.96) for cancer mortality.

Shows an association, not proof of cause and effect.

Zong G, Gao A, Hu FB, et al. Circulation, 2016. PMID 27297341

2016 / Dose-response meta-analysis of prospective studies

Higher whole grain intake was linked to lower risks of cardiovascular disease, total cancer, and all-cause mortality in prospective studies.

A systematic review and dose-response meta-analysis evaluated 45 prospective studies examining whole grain consumption and disease or mortality risks. A 90 g/day increase in whole grain intake was associated with a lower relative risk of coronary heart disease (RR 0.81, 95% CI 0.75 to 0.87), cardiovascular disease (RR 0.78, 95% CI 0.73 to 0.85), total cancer mortality (RR 0.85, 95% CI 0.80 to 0.91), and all-cause mortality (RR 0.83, 95% CI 0.77 to 0.90). Risk reductions were also seen for respiratory, infectious, and all non-cardiovascular non-cancer mortality, with risk reductions seen up to 210-225 g/day for most outcomes. Little evidence of an association was found for refined grains, white rice, total rice, or total grains.

Shows an association, not proof of cause and effect.

Aune D, Keum N, Giovannucci E, et al. BMJ, 2016. PMID 27301975

2016 / Meta-analysis of observational studies

Higher dietary cholesterol intake is associated with an increased risk of breast cancer.

A meta-analysis evaluated 9 observational articles (6 cohort studies and 3 case-control studies) regarding dietary cholesterol intake and breast cancer. The pooled relative risk for the highest versus lowest cholesterol intake was 1.29 (95% CI: 1.06-1.56). Dose-response modeling identified a nonlinear relationship, with the positive association reaching statistical significance when cholesterol intake exceeded 370 mg/d.

Shows an association, not proof of cause and effect.

Li C, Yang L, Zhang D, et al. Nutr Res, 2016. PMID 27333953

2016 / Cumulative meta-analysis of randomized controlled trials

Vitamin B supplementation did not alter overall cancer incidence or total mortality.

A meta-analysis of 18 randomized controlled trials with 74,498 participants evaluated vitamin B supplementation. Supplements did not affect cancer incidence (RR 1.04, 95% CI: 0.98 to 1.10), cancer mortality (RR 1.05, 95% CI: 0.90 to 1.22), or all-cause mortality (RR 1.00, 95% CI: 0.94 to 1.06). When evaluating individual malignancies, supplementation lowered the occurrence of skin melanoma (RR 0.47, 95% CI: 0.23 to 0.94).

Zhang SL, Chen TS, Ma CY, et al. Medicine (Baltimore), 2016. PMID 27495015

2016 / Dose-response meta-analysis of prospective studies

Higher nut intake was linked to lower risks of cardiovascular disease, total cancer, all-cause mortality, and several cause-specific mortalities.

A systematic review and dose-response meta-analysis evaluated 20 prospective studies examining nut consumption and mortality outcomes in adults. A 28 g/day increase in nut intake was associated with reduced risk of coronary heart disease (RR 0.71, 95% CI: 0.63-0.80), cardiovascular disease (RR 0.79, 95% CI: 0.70-0.88), total cancer (RR 0.85, 95% CI: 0.76-0.94), and all-cause mortality (RR 0.78, 95% CI: 0.72-0.84). Inverse associations were also observed for mortality from respiratory disease (RR 0.48), diabetes (RR 0.61), and infectious disease (RR 0.25), with similar findings for tree nuts and peanuts.

Shows an association, not proof of cause and effect.

Aune D, Keum N, Giovannucci E, et al. BMC Med, 2016. PMID 27916000

2016 / Systematic review and meta-analysis of prospective cohort studies

Whole-grain intake was associated with lower all-cause, cardiovascular, and cancer mortality.

A meta-analysis of 20 prospective cohort studies tracked 2,282,603 participants over 5.5 to 26 years, recording 191,979 deaths. An extra three daily servings (90 g/d) of total whole grains was associated with lower all-cause mortality (RR 0.83; 95% CI: 0.79, 0.88) and a 25% lower risk of cardiovascular mortality. Whole-grain consumption was also inversely associated with total cancer mortality (RR 0.94; 95% CI: 0.91, 0.98).

Shows an association, not proof of cause and effect.

Benisi-Kohansal S, Saneei P, Salehi-Marzijarani M, et al. Adv Nutr, 2016. PMID 28140323

2015 / Case-control study and meta-analysis of observational studies

Higher intake of allium vegetables, garlic, and onions was linked to lower gastric cancer risk, an association driven mainly by case-control studies.

Researchers evaluated allium vegetable intake and gastric cancer risk using an Italian case-control study (230 cases, 547 controls) and a meta-analysis (>10,000 cases). In the case-control study, odds ratios were 0.59 (95% CI, 0.25-1.41) for ≥2 portions of onion per week, 0.69 (95% CI, 0.41-1.15) for high garlic intake, and 0.70 (95% CI, 0.39-1.28) for frequent use of both. In the meta-analysis, pooled relative risks for highest versus lowest intake were 0.78 (95% CI, 0.67-0.91) for allium vegetables, 0.60 (95% CI, 0.47-0.76) for garlic, and 0.55 (95% CI, 0.41-0.73) for onion. However, the pooled relative risk for high allium vegetable intake from the four cohort studies was 1.02 (95% CI, 0.88-1.18), with authors noting further data from large cohorts are desirable.

Shows an association, not proof of cause and effect.

Turati F, Pelucchi C, Guercio V, et al. Mol Nutr Food Res, 2015. PMID 25215621

2015 / Meta-analysis of case-control, cohort, and randomized studies

Garlic intake was associated with a reduced risk of gastric cancer.

A meta-analysis of 14 case-control, two randomized, and one cohort study assessed garlic intake and gastric cancer risk among 8,621 cases and 14,889 controls. High garlic consumption was associated with lower gastric cancer risk (OR 0.49, 95% CI 0.38-0.62), as were low intake (OR 0.75, 95% CI 0.58-0.97) and any intake (OR 0.77, 95% CI 0.60-1.00). Substantial variation was observed in intake duration and exposure definitions across studies.

Kodali RT, Eslick GD Nutr Cancer, 2015. PMID 25411831

2015 / Dose-response meta-analysis

Heavy alcohol intake was linked to higher risk across multiple cancer types.

A meta-analysis evaluated 572 studies with 486,538 cancer cases across 23 malignancies. Compared to non- or occasional drinkers, heavy drinkers had higher risks for oral and pharyngeal cancer (RR 5.13), esophageal squamous cell carcinoma (RR 4.95), larynx (RR 2.65), gallbladder (RR 2.64), liver (RR 2.07), breast (RR 1.61), colorectum (RR 1.44), stomach (RR 1.21), pancreas (RR 1.19), and lung cancer (RR 1.15). Inverse associations were observed for Hodgkin's and non-Hodgkin's lymphomas.

Bagnardi V, Rota M, Botteri E, et al. Br J Cancer, 2015. PMID 25422909

2015 / Meta-analysis of prospective cohort studies

Dairy and dietary calcium intakes were linked to higher prostate cancer risk.

A meta-analysis of 32 prospective cohort studies evaluated dairy and calcium consumption in relation to prostate cancer. Greater risk was associated with total dairy (summary RR: 1.07; 95% CI: 1.02, 1.12 per 400 g/d), cheese (summary RR: 1.09; 95% CI: 1.02, 1.18 per 50 g/d), and dietary calcium (summary RR: 1.05; 95% CI: 1.02, 1.09 per 400 mg/d). Total and dairy calcium were also linked to increased risk, but nondairy calcium was not.

Shows an association, not proof of cause and effect.

Aune D, Navarro Rosenblatt DA, Chan DS, et al. Am J Clin Nutr, 2015. PMID 25527754

2015 / Meta-analysis

Higher serum 25-hydroxyvitamin D concentrations were associated with lower mortality in colorectal cancer patients.

A meta-analysis using a random-effects model evaluated the relationship between serum 25(OH)D concentrations at diagnosis and mortality in colorectal cancer patients. Patients in the highest quintile of 25(OH)D had 37% lower mortality compared to those in the lowest quintile (pooled odds ratio = 0.63, p < 0.0001). Dose-response curves showed lower hazard ratios for mortality with higher serum 25(OH)D through at least 40 ng/ml without exception. The authors noted that additional studies are needed to evaluate confounding or the possibility of reverse causation.

Shows an association, not proof of cause and effect.

Mohr SB, Gorham ED, Kim J, et al. J Steroid Biochem Mol Biol, 2015. PMID 25533386

2015 / Meta-analysis of observational studies

Higher dietary cholesterol intake was associated with increased pancreatic cancer risk

A meta-analysis of 16 articles including 4,513 pancreatic cancer cases evaluated the relationship between cholesterol consumption and disease risk. Higher cholesterol intake was associated with a higher risk of pancreatic cancer (summary RR 1.371, 95% CI 1.155-1.627), especially in America (summary RR 1.302, 95% CI 1.090-1.556). Linear dose-response modeling indicated that risk was linked to an 8% increase per 100 mg/day increment of dietary cholesterol (summary RR 1.08, 95% CI 1.04-1.13).

Shows an association, not proof of cause and effect.

Chen H, Qin S, Wang M, et al. Sci Rep, 2015. PMID 25649888

2015 / Meta-analysis of 17 cohort studies

Obesity was linked to an increased risk of aggressive prostate cancer and prostate cancer-associated mortality in a meta-analysis of cohort studies.

A meta-analysis of 17 cohort studies comprising 3,569,926 individuals evaluated the correlation between obesity and prostate cancer (PCa) incidence and mortality. Obesity was not significantly correlated with overall PCa incidence (RR, 1.00; 95% CI, 0.95-1.06). However, obesity was significantly associated with an increased risk of aggressive PCa (RR, 1.14; 95% CI, 1.04-1.25) and PCa-associated mortality (RR, 1.24; 95% CI, 1.15-2.33), with no heterogeneity across studies (I2=0.0%; P=0.847).

Shows an association, not proof of cause and effect.

Zhang X, Zhou G, Sun B, et al. Oncol Lett, 2015. PMID 25663903

2015 / Meta-analysis of prospective cohort studies

High diet quality indices were linked to lower mortality, cardiovascular disease, cancer, and diabetes.

A meta-analysis evaluated 15 prospective cohorts encompassing 1,020,642 participants. Top-tier adherence to HEI, AHEI, or DASH was associated with lower total mortality (RR 0.78, 95% CI 0.76 to 0.80), cardiovascular events or death (RR 0.78, 95% CI 0.75 to 0.81), malignancies (RR 0.85, 95% CI 0.82 to 0.88), and type 2 diabetes (RR 0.78, 95% CI 0.72 to 0.85). Neurodegenerative conditions showed no significant relationship.

Shows an association, not proof of cause and effect.

Schwingshackl L, Hoffmann G J Acad Nutr Diet, 2015. PMID 25680825

2015 / Meta-analysis of prospective cohorts

Higher legume intake is linked to lower colorectal cancer risk

A meta-analysis of 14 prospective cohort studies comprising 1,903,459 participants and 12,261 cases evaluated dietary legume intake and colorectal cancer risk. Higher legume consumption was associated with reduced risk (RR 0.91, 95% CI 0.84-0.98), with inverse associations observed in Asian cohorts (RR 0.82, 95% CI 0.74-0.91) and for soybean consumption (RR 0.85, 95% CI 0.73-0.99).

Shows an association, not proof of cause and effect.

Zhu B, Sun Y, Qi L, et al. Sci Rep, 2015. PMID 25739376

2015 / Two systematic reviews and product composition analysis

Evidence for the clinical effectiveness of pomegranate products in cancer treatment is poor due to poor study quality.

Researchers conducted two systematic reviews evaluating the effectiveness and safety of pomegranate products for cancer treatment, alongside product compositional analyses. Four clinical studies investigating three pomegranate products were identified, with one study considered inappropriate due to low polyphenol content. The evidence of clinical effectiveness was poor because study quality was poor. While the doses used in clinical studies showed no safety concerns, pomegranate preparations may induce synthetic drug metabolism through liver enzyme activation.

Vlachojannis C, Zimmermann BF, Chrubasik-Hausmann S Evid Based Complement Alternat Med, 2015. PMID 25815026

2015 / Systematic review and meta-analysis of case-control studies

Higher fried food consumption was linked to increased prostate cancer risk.

A systematic review and meta-analysis investigated the relationship between fried food intake and prostate cancer risk across four case-control studies. The analysis included 2,579 cancer patients and 2,277 matched controls. Greater intake of fried food was associated with a 35% higher risk of prostate cancer (95% CI: 17% to 57%).

Shows an association, not proof of cause and effect.

Lippi G, Mattiuzzi C Int J Food Sci Nutr, 2015. PMID 26114920

2015 / Dose-response meta-analysis of prospective cohort studies

Green and black tea intake were linked to lower risks of specific mortalities.

A dose-response meta-analysis of 18 prospective cohort studies examined tea intake and cause-specific mortality. Green tea consumption was inversely associated with cardiovascular mortality (highest vs. lowest RR 0.67; 95% CI: 0.46, 0.96) and all-cause mortality (RR 0.80; 95% CI: 0.68, 0.93). Black tea was inversely associated with cancer mortality (RR 0.79; 95% CI: 0.65, 0.97) and all-cause mortality (RR 0.90; 95% CI: 0.83, 0.98).

Shows an association, not proof of cause and effect.

Tang J, Zheng JS, Fang L, et al. Br J Nutr, 2015. PMID 26202661

2015 / Dose-response meta-analysis of prospective observational studies

High egg intake was associated with a modestly elevated risk of breast cancer.

A dose-response meta-analysis of prospective studies investigated egg intake and sex hormone-related cancers. Consuming at least 5 eggs per week was linked to increased breast cancer risk compared to no intake (RR 1.04; 95% CI: 1.01, 1.07 for 5 eggs/week; RR 1.09; 95% CI: 1.03, 1.15 for 9 eggs/week). An increase of 5 eggs weekly was also associated with fatal prostate cancer (RR 1.47; 95% CI: 1.01, 2.14), but not total prostate cancer.

Shows an association, not proof of cause and effect.

Keum N, Lee DH, Marchand N, et al. Br J Nutr, 2015. PMID 26293984

2015 / Meta-analysis of prospective cohorts

Night-shift work is linked to increased breast cancer and cardiovascular mortality risks

A meta-analysis of 16 prospective cohort studies including 2,020,641 participants examined night-shift work in relation to health outcomes. An increase in night-shift work was associated with incident breast cancer (RR 1.057, 95% CI 1.014-1.102) and cardiovascular death (RR 1.027, 95% CI 1.001-1.053). Longer duration showed higher breast cancer associations, reaching an RR of 1.088 (95% CI 1.012-1.169) for over 20 years, whereas all-cause death was not significantly associated (RR 1.253, 95% CI 0.786-1.997).

Shows an association, not proof of cause and effect.

Lin X, Chen W, Wei F, et al. Sleep Med, 2015. PMID 26498240

2014 / Systematic review of clinical trials and observational studies

Flaxseed intake is linked to lower breast cancer risk and improved survival

A systematic review examined 10 studies evaluating flaxseed and breast cancer. In randomized trials of newly diagnosed patients, 25 g daily of flax increased apoptotic index and reduced HER2 expression (both P < 0.05) relative to control. Observational investigations linked flax intake to lower primary breast cancer incidence (OR = 0.82; 95% CI: 0.69-0.97) and lower mortality (HR = 0.69; 95% CI: 0.50-0.95).

Flower G, Fritz H, Balneaves LG, et al. Integr Cancer Ther, 2014. PMID 24013641